Question 1

How many shares of VRDN does BlackRock, Inc. own?

Accepted Answer

As of 2026-Q2, BlackRock, Inc. holds 8.6M shares of VRDN (VIRIDIAN THERAPEUTICS INC).

Question 2

What is BlackRock, Inc.'s VRDN position worth?

Accepted Answer

As of 2026-Q2, BlackRock, Inc.'s VRDN position is worth $157.1M.

Question 3

Is BlackRock, Inc. buying or selling VRDN?

Accepted Answer

In 2026-Q2, BlackRock, Inc. increased their VRDN position (+9.2% change in shares).

Question 4

When did BlackRock, Inc. first buy VRDN?

Accepted Answer

Based on available 13F filings, BlackRock, Inc. first reported a position in VRDN in 2024-Q3. They have held the position across 8 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	8.6M	+9.2%	$157.1M	0.0%	$18.37	33
2026-Q1	Increased	7.8M	+21.8%	$153.2M	0.0%	$29.32	36
2025-Q4	Increased	6.4M	+18.5%	$200.2M	0.0%	$31.02	36
2025-Q3	Decreased	5.4M	-1.7%	$117.1M	0.0%	$21.61	0
2025-Q2	Decreased	5.5M	-3.3%	$77.2M	0.0%	$14.33	0
2025-Q1	Decreased	5.7M	-0.9%	$76.9M	0.0%	$14.44	0
2024-Q4	Increased	5.8M	+19.9%	$110.4M	0.0%	$19.17	36
2024-Q3	First report	4.8M	-	$109.3M	0.0%	$22.75	0

VRDN8 quarters

VRDN
8 quarters